Global Alzheimer’s Therapeutics Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 7122

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Europe is estimated to grow at a rapid pace owing to the high prevalence of AD coupled with ever improving diagnostic capabilities. Asia Pacific is expected to witness the fastest growth over the forecast period owing to the rising disposable income level.

The global Alzheimer’s Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Alzheimer’s Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alzheimer’s Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Pfizer
Merck &
Novartis AG
Eisai
H. Lundbeck A/S
AC Immune
TauRx Pharmaceuticals
Actavis plc.
Forest Laboratories
Teva Pharmaceuticals Industries
Janssen Pharmaceutical
GE healthcare
Eli Lilly And Company
DiaGenic ASA
VTV Therapeutics
Hoffman-La Roche
AstraZeneca
Daiichi Sankyo Company

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Donepezil
Memantine
Rivastigmine

Segment by Application
Early to Moderate Stages
Moderate to Severe Stages

Table of Contents

Executive Summary
1 Alzheimer’s Therapeutics Market Overview
1.1 Product Overview and Scope of Alzheimer’s Therapeutics
1.2 Alzheimer’s Therapeutics Segment by Type
1.2.1 Global Alzheimer’s Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.3 Alzheimer’s Therapeutics Segment by Application
1.3.1 Alzheimer’s Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Global Alzheimer’s Therapeutics Market by Region
1.4.1 Global Alzheimer’s Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Alzheimer’s Therapeutics Market Size
1.5.1 Global Alzheimer’s Therapeutics Revenue (2014-2025)
1.5.2 Global Alzheimer’s Therapeutics Production (2014-2025)

2 Global Alzheimer’s Therapeutics Market Competition by Manufacturers
2.1 Global Alzheimer’s Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Alzheimer’s Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Alzheimer’s Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Alzheimer’s Therapeutics Production Sites, Area Served, Product Types
2.5 Alzheimer’s Therapeutics Market Competitive Situation and Trends
2.5.1 Alzheimer’s Therapeutics Market Concentration Rate
2.5.2 Alzheimer’s Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Alzheimer’s Therapeutics Production Market Share by Regions
3.1 Global Alzheimer’s Therapeutics Production Market Share by Regions
3.2 Global Alzheimer’s Therapeutics Revenue Market Share by Regions (2014-2019)
3.3 Global Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Alzheimer’s Therapeutics Production
3.4.1 North America Alzheimer’s Therapeutics Production Growth Rate (2014-2019)
3.4.2 North America Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Alzheimer’s Therapeutics Production
3.5.1 Europe Alzheimer’s Therapeutics Production Growth Rate (2014-2019)
3.5.2 Europe Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Alzheimer’s Therapeutics Production (2014-2019)
3.6.1 China Alzheimer’s Therapeutics Production Growth Rate (2014-2019)
3.6.2 China Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Alzheimer’s Therapeutics Production (2014-2019)
3.7.1 Japan Alzheimer’s Therapeutics Production Growth Rate (2014-2019)
3.7.2 Japan Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Alzheimer’s Therapeutics Consumption by Regions
4.1 Global Alzheimer’s Therapeutics Consumption by Regions
4.2 North America Alzheimer’s Therapeutics Consumption (2014-2019)
4.3 Europe Alzheimer’s Therapeutics Consumption (2014-2019)
4.4 China Alzheimer’s Therapeutics Consumption (2014-2019)
4.5 Japan Alzheimer’s Therapeutics Consumption (2014-2019)

5 Global Alzheimer’s Therapeutics Production, Revenue, Price Trend by Type
5.1 Global Alzheimer’s Therapeutics Production Market Share by Type (2014-2019)
5.2 Global Alzheimer’s Therapeutics Revenue Market Share by Type (2014-2019)
5.3 Global Alzheimer’s Therapeutics Price by Type (2014-2019)
5.4 Global Alzheimer’s Therapeutics Production Growth by Type (2014-2019)

6 Global Alzheimer’s Therapeutics Market Analysis by Applications
6.1 Global Alzheimer’s Therapeutics Consumption Market Share by Application (2014-2019)
6.2 Global Alzheimer’s Therapeutics Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Alzheimer’s Therapeutics Business
7.1 Pfizer
7.1.1 Pfizer Alzheimer’s Therapeutics Production Sites and Area Served
7.1.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.1.3 Pfizer Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Merck &
7.2.1 Merck & Alzheimer’s Therapeutics Production Sites and Area Served
7.2.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.2.3 Merck & Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Novartis AG
7.3.1 Novartis AG Alzheimer’s Therapeutics Production Sites and Area Served
7.3.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.3.3 Novartis AG Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Eisai
7.4.1 Eisai Alzheimer’s Therapeutics Production Sites and Area Served
7.4.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.4.3 Eisai Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 H. Lundbeck A/S
7.5.1 H. Lundbeck A/S Alzheimer’s Therapeutics Production Sites and Area Served
7.5.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.5.3 H. Lundbeck A/S Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 AC Immune
7.6.1 AC Immune Alzheimer’s Therapeutics Production Sites and Area Served
7.6.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.6.3 AC Immune Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 TauRx Pharmaceuticals
7.7.1 TauRx Pharmaceuticals Alzheimer’s Therapeutics Production Sites and Area Served
7.7.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.7.3 TauRx Pharmaceuticals Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Actavis plc.
7.8.1 Actavis plc. Alzheimer’s Therapeutics Production Sites and Area Served
7.8.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.8.3 Actavis plc. Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Forest Laboratories
7.9.1 Forest Laboratories Alzheimer’s Therapeutics Production Sites and Area Served
7.9.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.9.3 Forest Laboratories Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Teva Pharmaceuticals Industries
7.10.1 Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Production Sites and Area Served
7.10.2 Alzheimer’s Therapeutics Product Introduction, Application and Specification
7.10.3 Teva Pharmaceuticals Industries Alzheimer’s Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Janssen Pharmaceutical
7.12 GE healthcare
7.13 Eli Lilly And Company
7.14 DiaGenic ASA
7.15 VTV Therapeutics
7.16 Hoffman-La Roche
7.17 AstraZeneca
7.18 Daiichi Sankyo Company

8 Alzheimer’s Therapeutics Manufacturing Cost Analysis
8.1 Alzheimer’s Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Alzheimer’s Therapeutics
8.4 Alzheimer’s Therapeutics Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Alzheimer’s Therapeutics Distributors List
9.3 Alzheimer’s Therapeutics Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Alzheimer’s Therapeutics Market Forecast
11.1 Global Alzheimer’s Therapeutics Production, Revenue Forecast
11.1.1 Global Alzheimer’s Therapeutics Production Growth Rate Forecast (2019-2025)
11.1.2 Global Alzheimer’s Therapeutics Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Alzheimer’s Therapeutics Price and Trend Forecast (2019-2025)
11.2 Global Alzheimer’s Therapeutics Production Forecast by Regions (2019-2025)
11.2.1 North America Alzheimer’s Therapeutics Production, Revenue Forecast (2019-2025)
11.2.2 Europe Alzheimer’s Therapeutics Production, Revenue Forecast (2019-2025)
11.2.3 China Alzheimer’s Therapeutics Production, Revenue Forecast (2019-2025)
11.2.4 Japan Alzheimer’s Therapeutics Production, Revenue Forecast (2019-2025)
11.3 Global Alzheimer’s Therapeutics Consumption Forecast by Regions (2019-2025)
11.3.1 North America Alzheimer’s Therapeutics Consumption Forecast (2019-2025)
11.3.2 Europe Alzheimer’s Therapeutics Consumption Forecast (2019-2025)
11.3.3 China Alzheimer’s Therapeutics Consumption Forecast (2019-2025)
11.3.4 Japan Alzheimer’s Therapeutics Consumption Forecast (2019-2025)
11.4 Global Alzheimer’s Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Alzheimer’s Therapeutics Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer